MRI of malignant Liver Lesions: Which MR Contrast Agent? Which diagnostic criteria?

Webinar 2

MRI of the Liver

It will address the choice of MR contrast agent in the suspicion or follow-up of focal hepatic malignant lesions most frequently observed in the clinical practice:

 

  • Hepatocellular Carcinoma (HCC)
  • Intrahepatic Cholangiocarcinoma (ICC) and combined hepatocellular cholangiocarcinoma (CHC)
  • Metastasis

 

 

SPEAKERS

Alain Luciani Head of the Medical and University Department for Medical Imaging at University Hospital Henri Mondor AP-HP, France

Luis Marti-Bonmati Director of medical imaging at La Fe University and Polytechnic University Hospital, and chief of radiology at Quirón Hospital, Valencia, Spain

Giovanni Morana Director of Diagnostic Radiology Dept. Ospedale Ca’ Foncello, Treviso, Italy

Günther Schneider Vice Chair Dept. of Diagnostic and Interventional Radiology, Head of MRI Saarland University Medical Center, Homburg, Germany

 

MODERATOR

Antonella Filippone MD, Head of Medical Affairs and Scientific Information, Bracco Imaging, Milan, Italy

OCTOBER 30
18:00 - 19:00 CET

 

Download your invitation

 

The content of the webinar series is intended for European physicians only.

How to attend the webinar

 

Please register at the following link. You’ll receive the link to join the webinar via email.

 

 

Register me

 

Would you like to know more?
Follow the other two webinars!

 

 

Webinar 1

MRI of the Liver:
Choosing the right Contrast Agent

 

 

Webinar 3

Diagnostic challenges of benign/incidental lesions
at Liver MRI and CEUS

Share Article